Preliminary Results of Phase 2 Open Label Study of Lorlatinib Monotherapy in Relapsed/Refractory ALK plus Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors Alessia Ripamonti,Andrea Aroldi,Federica Cocito,Luca Guerra, Lavinia Monaco, Bianca Maria Granelli,Lara Mussolin,Carlo Gambacorti-PasseriniBLOOD（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
